Poslední aktualizace :
19/11/2024
vėžio narkotikų   Docetaxel  
Įpurškimas
Tirpalų stabilumas Mišinių stabilumas Stabilumą lemiantys veiksniai Suderinamumas Leidimo būdai Bibliografija pdf
   Cheminė sandara  

Prekinis pavadinimas   Prekinis pavadinimas     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adenex Kolumbija
Asodocel Argentina
Axogen Čilė
Bagotaxel Čilė
Bendadocel Vokietija
Brecasta Čilė
Celtere Peru
Daxotel Čilė, Egiptas, Kolumbija, Malaizija
Doce NC Vokietija
Docefrez Indija, Jungtinės Amerikos Valstijos
Docekebir Argentina
Docetax Iranas, Venesuela
Docetaxin Vokietija
Docewin Marokas
Dolectran Argentina
Donataxel Argentina, Ekvadoras, Peru
Doxel Turkija, Venesuela
Doxetal Argentina
Doxitax Turkija
Oncodocel Kolumbija, Peru
Onkotaxel Austrija, Kolumbija
Ribodocel Vokietija
Santax Turkija
Tadocel Turkija
Taxceus Didžioji Britanija
Taxotan Vokietija
Taxotere Argentina, Australija, Austrija, Belgija, Čilė, Danija, Didžioji Britanija, Egiptas, Ekvadoras, Graikija, Iranas, Islandija, Ispanija, Italija, Japonija, Jungtinės Amerikos Valstijos, Jungtiniai Arabų Emyratai, Kanada, Kolumbija, Kroatija, Lenkija, Liuksemburgas, Malaizija, Marokas, Meksikas, Naujojoje Zelandijoje, Norvegija, Olandija, Portugalija, Prancūzija, Rumunija, Saudo Arabija, Suomija, Švedija, Šveicarija, Tailandas, Tunisas, Turkija, Venesuela, Vengrija, Vokietija
Texot Argentina
Tolnexa Rumunija
Zenotere Indija, Peru
Bibliografija   Įpurškimas   Bibliografija : Docetaxel  
tipas leidinys
140 Žurnalas Pearson SD, Trissel LA.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Am J Hosp Pharm 1993 ; 50: 1405-1409.
250 Žurnalas Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Am J Health-Syst Pharm 1997 ; 54: 566-569.
251 Žurnalas Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423 Žurnalas Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1660 Žurnalas Thiesen J, Krämer I.
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Pharm World Sci 1999 ; 21: 137-141.
1662 Žurnalas Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1754 Žurnalas Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1940 Žurnalas Xu QA, Trissel LA.
Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953 Žurnalas Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 Žurnalas Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175 Žurnalas Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J.
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
J Pharm Clin 2006 ; 25, 3: 147-152.
2210 Žurnalas Walker S.E, Charbonneau F, Law S.
Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262 Žurnalas Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341 plakatas Bourlon S, Sautou-Miranda V, Dalle M.
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Poster ESCP Stockholm May 2005
3130 Laboratorija Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
Sanofi Avantis France 2009
3163 Žurnalas Acott SR, Hart M.
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
EJHP 2010 ; 16, 5: 26-28.
3195 Žurnalas MacLeod S, Sewell G.
Physical and chemical stability of docetaxel infusions.
EJHP 2011 ; 17, 2: 39-43.
3215 Žurnalas Hart MC, Ahmed W.
Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution.
EJOP 2011 ; 5,1: 24-27.
3277 Žurnalas Yang Z, Cameron S, Paul H.
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804 Žurnalas Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.
Physicochemical stability of cabazitaxel and docetaxel solutions.
EJHP 2014 ;22:150-155.
3937 Žurnalas Park K.H, Chung D.J.
Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration.
Biomat Res 2015 ; 19, 2

  Mentions Légales